Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants

August 26, 2019 updated by: Cynthia McEvoy, Oregon Health and Science University
The primary aim of this study is to quantify and compare changes in lung volumes (as measured by functional residual capacity) in premature infants stable on continuous positive airway pressure (CPAP), and then randomized to two additional weeks of CPAP and room air versus room air alone. We hypothesize that infants randomized to additional CPAP will demonstrate an increased functional residual capacity (at the end of the two week study period and prior to discharge) compared to those randomized to room air.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oregon
      • Portland, Oregon, United States, 97239
        • Oregon Health & Science University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 1 year (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Gestational age at birth <33 weeks
  • Required CPAP for a minimum of 24 hours for respiratory distress
  • Patient on CPAP and room air at time of randomization

Exclusion Criteria:

  • Complex congenital heart disease other than patent ductus arteriosus or atrial septal defect
  • Major malformations or chromosomal anomalies
  • Multiple gestation greater than twins
  • Culture proven sepsis or unstable at time of randomization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: CPAP and room air
Stable premature infants on CPAP and room air will be randomized to stay on CPAP for an additional two weeks.
Stable premature infants on CPAP and room air and meeting specific stability criteria will be randomized to stay on continuous positive airway pressure and room air for an additional two weeks or will be transitioned to room air alone.
Other Names:
  • continuous positive airway pressure
No Intervention: Room air
Premature stable infants on CPAP and room air will be randomized to transition to room air alone.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in the Measurements of Functional Residual Capacity (FRC) in Randomized Premature Infants
Time Frame: Just prior to randomization, two weeks later and at discharge (an average of 34 to 37 weeks of corrected gestational age).
Functional residual capacity (FRC) was measured with the nitrogen washout technique. For the nitrogen washout technique, calibration is done with 2 known volumes, and a calibration line was constructed for the system at the specific flow rate and used to correlate the nitrogen washed out to the infant's FRC. The system corrected for dead space and corrected the FRC to body temperature, pressure, and water-saturated conditions. Acceptance criteria included: 1) infant supine and quietly asleep; 2) test initiated at end expiration; 3) no evidence of leak on tracing of the washout; 4) consistent tracings; 5) at least 2-3 measurements with a coefficient of variation <10%. These are testing and acceptance criteria outlined by the American Thoracic Society and European Respiratory Society.
Just prior to randomization, two weeks later and at discharge (an average of 34 to 37 weeks of corrected gestational age).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurements of Passive Respiratory Compliance in Randomized Premature Infants
Time Frame: Just before randomization, two weeks later, and at discharge at about 35-37 weeks of corrected gestational age
Measurements of passive respiratory compliance will be done with the single breath occlusion technique.
Just before randomization, two weeks later, and at discharge at about 35-37 weeks of corrected gestational age
Passive Respiratory Resistance in Randomized Premature Infants
Time Frame: Just prior to randomization, two weeks after randomization, and at discharge at about 35-37 weeks of corrected gestational age.
Measurements of passive respiratory resistance will be done with the single breath occlusion technique.
Just prior to randomization, two weeks after randomization, and at discharge at about 35-37 weeks of corrected gestational age.
Measurements of Tidal Flow Volume Loops Will be Done in the Randomized Premature Infants.
Time Frame: Just before randomization, two weeks later, and at discharge at about 35-37 weeks of corrected gestational age.
Characteristics of tidal flow volume loops will be measured.
Just before randomization, two weeks later, and at discharge at about 35-37 weeks of corrected gestational age.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in the Growth Parameters Between the Randomized Premature Infants
Time Frame: From randomization through discharge at about 35-37 weeks of corrected gestational age.
Changes in growth parameters will be compared between randomized groups.
From randomization through discharge at about 35-37 weeks of corrected gestational age.
The Number of Participants With Adverse Events and Serious Adverse Events in the Randomized Groups of Premature Infants.
Time Frame: From randomization through discharge from the neonatal intensive care unit (an average of 35 to 37 weeks of corrected gestational age).
Adverse events and serious adverse events occurring in the randomized groups will be documented carefully
From randomization through discharge from the neonatal intensive care unit (an average of 35 to 37 weeks of corrected gestational age).
Corrected Gestational Age at Which Full Nipple Feeds Are Achieved
Time Frame: Randomization through discharge at about 35-37 weeks of corrected gestational age.
The corrected gestational age at which full nipple feeds are achieved will be compared between the randomized groups.
Randomization through discharge at about 35-37 weeks of corrected gestational age.
Incidence of Wheezing Through One Year of Age
Time Frame: Discharge through one year of corrected age
Incidence of wheezing will be compared through one year of corrected gestational age between the randomized groups.
Discharge through one year of corrected age
Cost Comparison Between Randomized Groups
Time Frame: Through 12 months of corrected age
Cost comparison through 12 months of corrected gestational age between the randomized groups per percent improvement in FRC measured at discharge between the groups.
Through 12 months of corrected age
Days on Oxygen Between the Randomized Groups
Time Frame: Through discharge at about 35-37 weeks of corrected gestational age
The days of oxygen supplementation will be compared between the groups of randomized patients.
Through discharge at about 35-37 weeks of corrected gestational age
Days in the Hospital
Time Frame: Delivery through discharge at about 35-37 weeks of corrected gestational age
The days in the hospital will be compared between the randomized groups.
Delivery through discharge at about 35-37 weeks of corrected gestational age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cindy T McEvoy, MD, MCR, Oregon Health and Science University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2014

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

September 1, 2017

Study Registration Dates

First Submitted

August 28, 2014

First Submitted That Met QC Criteria

September 22, 2014

First Posted (Estimate)

September 25, 2014

Study Record Updates

Last Update Posted (Actual)

August 29, 2019

Last Update Submitted That Met QC Criteria

August 26, 2019

Last Verified

August 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Distress Syndrome

Clinical Trials on CPAP and room air

3
Subscribe